Work

Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19

Year: 2021
Type: article
Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major global health threat. Mortality is predominantly caused by severe respiratory failure related to interstitial pneumonia in both lungs and acute respiratory distress syndrome. Recently, genome-wide association studies (GWASs) have identified chromosome 3p21.31 (sentinel variant: rs11385942) to be associated with both severe and general affected COVID-19 cases. 1 Despite of several coding genes mapped to the chromosome 3p21.31 locus (Fig. 1a ), the causal genes responsible for this locus remains largely illusive. Here, we performed both genome and epigenome editing approaches in potentially disease-relevant cell types to identify the causal genes regulated by this locus. Fig. 1 CRISPR/Cas genome editing identified CCR9 and SCL6A20 as target genes responsible for the chromosome 3p21.31 locus associated with severe COVID-19. a Regional association plots of the chromosome 3p21.31 locus associated with severe COVID-19 with respiratory failure. Association data was from Ellinghaus et al. study 1 . The linkage disequilibrium values were calculated on the basis of the 1000 Genomes project (European panel). The positions in the genome assembly hg19 are plotted. The recombination rate is shown in centimorgans (cM) per million base pairs (Mb). The purple diamond represents the variant most strongly associated with severe COVID-19 and respiratory failure. b Schematic diagram of genome editing strategy. The positions of sgRNAs and PAM sequences are shown in blue and red, respectively. The locations of PCR primers are indicated by arrows. F, forward; R, reverse. Clones of bi-allelic deletion are indicated by the presence of PCR product from F1+R1, but absence of PCR product from F2+R2. c , f , h Sequence of isogenic clonal deletions of the chromosome 3p21.31 locus obtained using CRISPR/Cas9 genome editing in 16HBE14o-, THP-1, and Jurkat cells, respectively. “Predicted” sequence indicates 67.8-kb deletion without any indel mutagenesis. For clones with bi-allelic deletion (see Fig. S3 ), genomic sequences were confirmed by cloning of each allele followed by Sanger sequencing. d Genes within 1 megabase covering the chromosome 3p21.31 locus, expressed in different cell types, were ascertained by RT-PCR. e , g , i Altered gene expression in clonal isogenic deletions in 16HBE14o-, THP-1, and Jurkat cells, respectively. RT-qPCR analysis of genes within 1 megabase covering the chromosome 3p21.31 locus was performed. Student’s t test was performed for each gene ( n = 3 technical replicates). * P < 0.05, ** P < 0.01. j Epigenetic programming at the chromosome 3p21.31 locus. Density maps are shown for DNase-Seq, ChIP-seq of active histone marks (H3K27ac and H3K4me1), repressive H3K9me3, and promoter mark (H3K4me3), in primary human T cells, B cells, and monocytes, as well as K562 cell lines. Locations of candidate causal variants from fine-mapping analysis were indicated by short vertical lines. Genomic locations in hg19 presented. Epigenetic datasets were obtained from the ENCODE Project (see Supplementary methods ) Full size image
Language: English
Subfield: Genetics
Open Access status: gold
Estimated APC paid: $2,775
OpenAlex ID: W3131097705
FWCI: 4.653
Cites: 5
Cited by: 50
Related to: 7